P2‐035: Ursodeoxycholic acid is associated with an improved liver transplantation‐free survival in primary biliary cholangitis

首页> 外文期刊>Journal of viral hepatitis. >P2‐035: Ursodeoxycholic acid is associated with an improved liver transplantation‐free survival in primary biliary cholangitis

【24h】

P2‐035: Ursodeoxycholic acid is associated with an improved liver transplantation‐free survival in primary biliary cholangitis

机译：P2-035：核致氧胆酸与原发性胆管炎的改善无肝移植存活相关

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of viral hepatitis.》 |2018年第s1期|共1页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类传染病;
关键词

相似文献

外文文献
中文文献
专利

1. P2‐035: Ursodeoxycholic acid is associated with an improved liver transplantation‐free survival in primary biliary cholangitis [J] . Journal of viral hepatitis. . 2018,第S1期

机译：P2-035：核致氧胆酸与原发性胆管炎的改善无肝移植存活相关
2. Prognostic Factors for Transplant-Free Survival and Validation of Prognostic Models in Chinese Patients with Primary Biliary Cholangitis Receiving Ursodeoxycholic Acid [J] . Ka-ShingCheung, Wai-KaySeto, JamesFung, Clinical and Translational Gastroenterology . 2017,第6期

机译：中国原发性胆汁性胆管炎接受熊去氧胆酸患者无移植生存的预后因素及预后模型的验证
3. Ursodeoxycholic Acid is Associated with a Prolonged Transplant-free Survival in All Patients with Primary Biliary Cholangitis - there is no such thing as non-response. [J] . van der Meer Adriaan J., Harms Maren H., Corpechot Christophe, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2017,第Suppla1期

机译：核致氧胆酸与所有原发性胆管炎的患者延长的无血管内生存率相关 - 没有反应的东西。
4. Dose effect of ursodeoxycholic acid used in the treatment of primary biliary cirrhosis and primary sclerosing cholangitis [C] . K. D. LINDO Falk Symposium . 2005

机译：熊毒胆酸的剂量效应用于治疗原发性胆汁肝硬化和原发性胆管炎
5. Predicting outcomes post liver transplantation in patients with primary biliary cirrhosis and primary sclerosing cholangitis. [D] . Zapatochny Rufo, Rebecca Jo. 2003

机译：预测原发性胆汁性肝硬化和原发性硬化性胆管炎患者肝移植后的结局。
6. Prognostic Factors for Transplant-Free Survival and Validation of Prognostic Models in Chinese Patients with Primary Biliary Cholangitis Receiving Ursodeoxycholic Acid [O] . Ka-Shing Cheung, Wai-Kay Seto, James Fung, 2017

机译：中国原发性胆源性胆管炎患者接受熊去氧胆酸的无移植存活预后因素及预后模型验证
7. Effects of Age and Sex of Response to Ursodeoxycholic Acid and Transplant-free Survival in Patients With Primary Biliary Cholangitis [O] . Angela C. Cheung, Willem J. Lammers, Carla F. Murillo Perez, 2019

机译：年龄和性别对核糖核酸患者核糖胆酸的反应和无移植生存的影响

P2‐035: Ursodeoxycholic acid is associated with an improved liver transplantation‐free survival in primary biliary cholangitis

著录项

相似文献

相关主题

期刊订阅